-
Careful Research Investments Yield Big Results
Read time: 3 minutes. When Erin Schenk, MD, PhD, began her journey as a junior faculty member at the University of Colorado, she treated patients with various types of lung cancer -
2025 ASCO: Highlights of Lung Cancer Research
Read time: 9 minutes. The annual meeting of the American Society of Clinical Oncology (ASCO) once again brought together nearly 50,000 members of the oncology community. From May -
Understanding DTPCs: A Path to Ending Drug Resistance in Lung Cancer
Read time: 2 minutes. When a person is treated for advanced-stage lung cancer, tumors will often shrink, and their symptoms may subside. An effective treatment will kill many tumor -
Committed to Cachexia: A Decade of LUNGevity Research
Read time: 4 minutes. LUNGevity Foundation stands at the forefront of lung cancer research and advocacy, driven by a mission to improve outcomes for patients through research -
Sharing Experiences With EGFR Lung Cancer: A Tool Shaped by Patients and Caregivers
Read time: 3 minutes. Why did we build a tool to visualize data collected from patients and caregivers? Community members provide data but too often never see how their data was -
A Future of Unifying Cancer Science and Medicine: Highlights from AACR 2025
Read time: 9 minutes. More than 22,000 cancer researchers from 81 countries got together for the annual American Association for Cancer Research (AACR) meeting in Chicago from